Strengthen your path to product approval
Cencora supports new marketing authorization applications across NDA, BLA, and MAA pathways and more. Our team can manage part or all of the submission process across Modules 1 to 5, aligning inputs, timelines, and regional requirements.
We also provide an independent submission readiness assessment that reviews the full dossier as one connected scientific, strategic, and operational narrative. That helps you identify cross-functional gaps, reduce review risk, and file with greater confidence.
We also provide an independent submission readiness assessment that reviews the full dossier as one connected scientific, strategic, and operational narrative. That helps you identify cross-functional gaps, reduce review risk, and file with greater confidence.
Address the risks that often derail filings
Marketing applications face rising scientific, regulatory, and operational complexity. Cencora helps you spot hidden gaps early and strengthen the submission before health authorities do.
Shifting expectations
Health authorities look beyond technical completeness to test whether the full dossier tells a consistent, credible, cross-functional benefit-risk story.
Scientific complexity
Complex products create interdependencies across CMC, clinical, nonclinical, and safety evidence that can surface as major questions during review.
Compressed timelines
Accelerated pathways leave less time to reconcile gaps, align stakeholders, and correct weaknesses once final submission work is underway.
Integrated submission support
You get operational and strategic support for new marketing authorization applications, from dossier planning and coordination through readiness review.
Our multidisciplinary team evaluates your submission across regulatory strategy and operations, CMC, clinical and nonclinical science, pharmacovigilance, labeling, market access and health economics and outcomes research (HEOR), and data science.
Our multidisciplinary team evaluates your submission across regulatory strategy and operations, CMC, clinical and nonclinical science, pharmacovigilance, labeling, market access and health economics and outcomes research (HEOR), and data science.
What we offer
Submission planning
Plan dossier scope, responsibilities, and timelines across stakeholders to support organized execution from preparation through filing.
Module authoring
Develop and coordinate content across Modules 1 to 5 to meet regional and national submission requirements.
Readiness review
Assess the full application as one connected narrative to identify gaps before the dossier reaches health authorities.
Risk analysis
Evaluate cross-functional dependencies that can weaken comparability, safety positioning, labeling alignment, or overall benefit-risk coherence.
Remediation guidance
Prioritize findings and recommend actions that strengthen the application and may reduce the need for new studies.
Data science support
Use analytical review to flag inconsistencies, weak links, and emerging risk areas for deeper expert assessment.
Why choose Cencora for integrated submission readiness assessment
Integrated review model
See how regulatory, CMC, clinical, safety, and labeling decisions work together across the full submission narrative.
Global operational support
Get regional and national regulatory expertise at every stage to help meet health authority requirements.
Broad product experience
Draw on expertise across small molecules, biologics, devices, biosimilars, generics, and advanced therapy submissions.
Expert insight
While there are many processes involved in commercializing a product in Europe, there are interdependencies between each of these steps. It is therefore important that sponsors eager to enter the European market avoid working in silos.
— Eva Keck and Marie-Charlotte von Brevern
Roadmap to pharmaceutical commercialization in Europe
Related solutions
Regulatory writing
Turn complex scientific, clinical, and quality data into clear, accurate, submission-ready documents across development and lifecycle management.
Publishing and electronic submission services
Run regulatory publishing and electronic submissions end to end, from planning and eCTD assembly through validation, publishing, and lifecycle maintenance.
PharmaLex is now Cencora
Integrated submission readiness assessment is part of our Commercialization support capability. Same team, same expertise, now with greater reach.
Need more information about integrated submission readiness assessment?
Our team of experts is here to assist you. Whether you have questions or need more detailed information, don’t hesitate to get in touch. We’re dedicated to providing the support you need.